Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 81 Records) |
| Query Trace: Recurrence and NRAS[original query] |
|---|
| Intragenic NF1 deletions in sinonasal mucosal malignant melanoma. Pigment cell & melanoma research 2021 Sep . Riobello Cristina, Casanueva Muruais Rodrigo, Suárez-Fernández Laura, García-Marín Rocío, Cabal Virginia N, Blanco-Lorenzo Verónica, Franchi Alessandro, Laco Jan, López Fernando, Llorente José Luis, Hermsen Mario |
| Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study. Molecular oncology 2021 9 16 (2): 549-561. Zhu Gui-Qi, Liu Wei-Ren, Tang Zheng, Qu Wei-Feng, Fang Yuan, Jiang Xi-Fei, Song Shu-Shu, Wang Han, Tao Chen-Yang, Zhou Pei-Yun, Huang Run, Gao Jun, Sun Hai-Xiang, Ding Zhen-Bin, Peng Yuan-Fei, Dai Zhi, Zhou Jian, Fan Jia, Shi Ying-Ho |
| Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. BMC genomics 2021 7 22 (1): 576. Lin Ruoting, Fogarty Conor E, Ma Bowei, Li Hejie, Ni Guoying, Liu Xiaosong, Yuan Jianwei, Wang Tianfa |
| Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer. Frontiers in molecular biosciences 2021 6 8 568818. Sun Jie, Xu Jinling, Sun Chao, Zheng Minying, Li Yuwei, Zhu Siwei, Zhang Shi |
| Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck. Acta oto-laryngologica 2021 12 142 (1): 94-99. Guo Wei, Yin Gaofei, Cui Chuanliang, Kong Yan, Huang Zhigang, Chen Xiaoho |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer. British journal of cancer 2022 Jun . Hashimoto Taiki, Takayanagi Daisuke, Yonemaru Junpei, Naka Tomoaki, Nagashima Kengo, Yatabe Yasushi, Shida Dai, Hamamoto Ryuji, Kleeman Sam O, Leedham Simon J, Maughan Timothy, Takashima Atsuo, Shiraishi Kouya, Sekine Shige |
| Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Scientific reports 2022 4 12 (1): 6752. Zhao Haiqiu, Dong Zhenkun, Wan Dingming, Cao Weijie, Xing Haizhou, Liu Zhenzhen, Fan Jixin, Wang Haiqiong, Lu Runqing, Zhang Yinyin, Cheng Qianqian, Jiang Zhongxing, He Fei, Xie Xinsheng, Guo Ro |
| Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort. The Journal of investigative dermatology 2022 4 142 (10): 2733-2743.e9. Chang Gregory A, Robinson Eric, Wiggins Jennifer M, Zhang Yilong, Tadepalli Jyothirmayee S, Schafer Christine N, Darvishian Farbod, Berman Russell S, Shapiro Richard, Shao Yongzhao, Osman Iman, Polsky Dav |
| Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma. Melanoma research 2022 Feb . Hotz Meghan J, O'Halloran Eileen A, Hill Maureen V, Hayden Kelly, Zaladonis Angela G, Deng Mengying, Olszanski Anthony J, Reddy Sanjay S, Wu Hong, Luo Biao, Farma Jeffrey |
| Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report. Case reports in women's health 2022 2 34 e00395. Silva R, Moran B, Das S, Mulligan N, Doughty M, Treacy A, Sheahan K, Kelly C M, Duffy A G, Perry A S, Brennan D |
| PRAME Staining in Sinonasal Mucosal Melanoma: A Single-Center Experience. Head and neck pathology 2022 12 . Scheurleer W F Julius, Braunius W Weibel, Tijink Bernard M, Suijkerbuijk Karijn P M, Dierselhuis Miranda P, Meijers Ruud W J, Blokx Willeke A M, de Bree Remco, Breimer Gerben E, Rijken Johannes |
| Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience. Virchows Archiv : an international journal of pathology 2022 11 . Xu Bin, Lubin Daniel J, Dogan Snjezana, Ghossein Ronald A, Viswanathan Kart |
| Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing. Molecular carcinogenesis 2022 10 62 (2): 200-209. Hou Yue, Zi Jie, Liu Shuo, Ge Qinyu, Ge Zhe |
| [Analysis of BRAF and NRAS mutations in thyroid tumors in patients from Argentina]. Medicina 2023 8 83 (4): 505-513. Esteban M Repetto, Lucía Fernandez, Roberto Lambertini, Ana Del Valle Jaen, Verónica Ruda Vega, Sofía Moldes, Ruben Lutfi, Claudio Aranda, Eduardo Faure, Adriana One |
| Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of TP53 mutations in a real-world setting. Hematology (Amsterdam, Netherlands) 2023 6 28 (1): 2223866. Hong Liu, Yuye Shi, Shandong Tao, Yunjie Li, Chunling Wang, Liang |
| Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment. Anticancer research 2023 4 43 (5): 2015-2024. Elena Orlandi, Andrea Romboli, Chiara Citterio, Serena Trubini, Stefano Vecchia, Maria Angela Palladino, Patrizio Capelli, Luigi Cavan |
| Malignant Melanoma in Older Adults: Different Patient or Different Disease? Cureus 2023 3 15 (2): e34742. Sasson Daniel C, Smetona John T, Parsaei Yassmin, Papageorge Marianna, Ariyan Stephan, Olino Kelly, Clune Jam |
| RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder. The American journal of surgical pathology 2023 12 . Keiichiro Kitahama, Yasuyuki Shigematsu, Gulanbar Amori, Emiko Sugawara, Junji Yonese, Junji Shibahara, Kengo Takeuchi, Kentaro Inamu |
| Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 2023 12 3 (12): 2510-2517. Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria S Higbie, Kanwal P S Raghav, Benny Johnson, Arvind Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Scott Kopetz, Michael J Overman, Van Karlyle Morr |
| [Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage ?-? melanoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2023 11 45 (11): 973-980. Z G Ren, Y Xu, Z Z Hua, Z Y Mo, L W Wang, G B Shi, W L Liu, W Sun, B Q Zheng, C M Wang, Y J Jin, Y Ch |
| Clinical, Imaging, and Pathological-Molecular Characteristics Associated with Stage IA Invasive Lung Adenocarcinoma Recurrence After Sub-lobar Resection. Academic radiology 2024 7 . Xin Fan, Chen Liang, Xueqin Ma, Qi |
| Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain. International journal of molecular sciences 2024 7 25 (13): . Natalia Castrejon, Roberto Martin, Antonio Carrasco, Paola Castillo, Adriana Garcia, Raquel Albero-González, Mireia García, Marta Marginet, Núria Palau, Mónica Hernández, Carla Montironi, Guillem Clot, Ana Arance, Llucia Alos, Cristina Teixi |
| Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study. International journal of cancer 2024 6 . Manja Bloem, Olivier J van Not, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Willeke A M Blokx, Marye J Boers-Sonderen, Johannes J Bonenkamp, Jan-Willem B de Groot, John B Haanen, Geke A P Hospers, Ellen W Kapiteijn, Melissa M de Meza, Djura Piersma, Rozemarijn S van Rijn, Marion A M Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil, Alfons J M van den Eertwegh, Karijn P M Suijkerbuijk, Michel W J M Woute |
| Exploring RAS mutation incidence and temporal heterogeneity in metastatic colorectal cancer patients - a single-institution experience utilising circulating tumour DNA. Contemporary oncology (Poznan, Poland) 2024 5 28 (1): 45-50. George Zarkavelis, Anna Lea Amylidi, Nanteznta Torounidou, Melina Yerolatsite, Athanasia Keravasili, Varvara Keramisanou, Davide Mau |
| Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review. Diagnostics (Basel, Switzerland) 2024 5 14 (10): . Elena Orlandi, Mario Giuffrida, Serena Trubini, Enrico Luzietti, Massimo Ambroggi, Elisa Anselmi, Patrizio Capelli, Andrea Rombo |
| Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer. JAMA network open 2024 5 7 (5): e2411919. Guodong Fu, Ronald S Chazen, Christina MacMillan, Ian J Witteri |
| Low incidence of BRAF and NRAS mutations in a population with a high incidence of melanoma. Virchows Archiv : an international journal of pathology 2024 1 . Grace Neville, Barbara Marzario, David Shilling, Collette K Hand, Cynthia Heffr |
| TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
| Whether Detection of Gene Mutations Could Identify Low- or High-Risk Papillary Thyroid Microcarcinoma? Data from 393 Cases Using the Next-Generation Sequencing. International journal of endocrinology 2024 1 2024 2470721. Lei Jin, Liang Zhou, Jian-Biao Wang, Li Tao, Xiao-Xiao Lu, Na Yan, Qian-Ming Chen, Li-Ping Cao, Lei X |
- Page last reviewed:Feb 1, 2024
- Content source: